| Pharmaceutical active ingredients: |
| Niflumic Acid |
| Available forms, composition and doses of Nifluril: |
| Capsules; Oral; Niflumic Acid 250 mgOintment; Topical; Niflumic Acid 3% |
| Nifluril medical category: |
| Human:Cyclooxygenase-2 inhibitorsJoint and muscular pain treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX02 - Niflumic AcidM02AA17 - Niflumic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbUPSA LaboratoiresUpsamedicaWing Wai Trading |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Niflec | Macrogol 4000; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate | Meiji Indonesian Pharmaceutical Industries |
| Niflex | Ethoxyquin | Unidentified Pharmaceutical Company |
| Niflex D | Ethoxyquin | Unidentified Pharmaceutical Company |
| Niflucan | Flunarizine | Duncan Laboratorios |
| Niflugel | Niflumic Acid | Bristol-Myers Squibb; UPSA Laboratoires; Upsamedica |
| Nifluril Dental Gel | Hexetidine; Niflumic Acid Glycinamide | Bristol-Myers Squibb; UPSA Laboratoires |
| Nifluril Suppositories | Morniflumate | Bristol-Myers Squibb; UPSA Laboratoires; Upsamedica; Wing Wai Trading |
| Niflux | Carbocisteine; Sobrerol | Alodial Farmaceutica |
| Nifolin | Folic Acid | Unidentified Pharmaceutical Company |
| Nifopress | Nifedipine | Goldshield Pharmaceuticals |